UNITED ~~STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549~~STATES

~~FORM~~SECURITIES ~~8-K~~AND EXCHANGE COMMISSION

~~CURRENT~~Washington, ~~REPORT~~D.C. 20549

~~Pursuant~~FORM ~~to Section 13 or 15(d) of the Securities Exchange Act of 1934~~8-K

~~Date~~CURRENT ~~of Report (Date of earliest event reported): July 24, 2026~~REPORT

~~HCA~~PURSUANT ~~Healthcare,~~TO ~~Inc.~~SECTION 13 OR 15(d)

~~(Exact~~OF ~~name~~THE ofSECURITIES ~~Registrant~~EXCHANGE asACT ~~Specified~~OF ~~in Its Charter)~~1934

Delaware	001-11239	27-3865930
(State or Other Jurisdictionof Incorporation)	(Commission File Number)	(IRS EmployerIdentification No.)
One Park Plaza
Nashville, Tennessee		37203
(Address of Principal Executive Offices)		(Zip Code)

Date of Report (Date of earliest event reported): July 29, 2026

~~Registrant’s~~ ~~Telephone~~HCA ~~Number~~HEALTHCARE, ~~Including~~INC. ~~Area Code: (615) 344-9551~~

~~Not~~(Exact ~~Applicable~~name of registrant as specified in its charter)

(Former Name or Former Address, if Changed Since Last Report)

Delaware

001-11239

27-3865930

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


One Park Plaza, Nashville, Tennessee		37203
(Address of principal executive offices)		(Zip Code)

~~☐Written~~Registrant’s ~~communications~~telephone ~~pursuant~~number, toincluding ~~Rule~~area ~~425~~code: ~~under the Securities Act~~ (~~17 CFR 230.425~~615) 344-9551

~~☐Soliciting~~Not ~~material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)~~Applicable

~~☐Pre-commencement~~(Former ~~communications~~name ~~pursuant~~or toformer ~~Rule~~address, ~~14d-2(b)~~if ~~under~~changed ~~the~~since ~~Exchange~~last ~~Act (17 CFR 240.14d-2(b~~report))

~~☐Pre~~Check the appropriate box below if the Form 8-~~commencement~~K ~~communications~~filing ~~pursuant~~is intended to ~~Rule~~simultaneously ~~13e-4(c)~~satisfy the filing obligation of the registrant under any of the ~~Exchange~~following ~~Act~~provisions (17see ~~CFR~~General ~~240~~Instruction A.~~13e-4(c~~2. below)):

~~Securities~~☐ ~~registered~~Written communications pursuant to ~~Section~~Rule ~~12(b)~~425 ofunder the Securities Act: (17 CFR 230.425)

Title of each class		TradingSymbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value per share		HCA		New York Stock Exchange

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

~~Indicate~~☐ byPre-commencement ~~check~~communications ~~mark~~pursuant ~~whether~~to ~~the registrant is an emerging growth company as defined in~~ Rule ~~405 of the Securities Act of 1933~~ 14d-2(~~§230.405 of this chapter~~b) orunder ~~Rule 12b-2 of~~ the ~~Securities~~ Exchange Act of(17 ~~1934~~CFR (§240.~~12b~~14d-2 ~~of this chapter~~(b). )

~~Emerging~~☐ ~~growth~~Pre-commencement ~~company~~communications ☐pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

IfSecurities anregistered ~~emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided~~ pursuant to Section 13 12(ab) of the ~~Exchange~~ Act~~. ☐~~:

Item 2.02. Results of Operations and Financial Condition.

Title of each class

Trading
Symbol(s)

Name of each exchange

on which registered

Common Stock, $.01 par value per share

HCA

New York Stock Exchange

OnIndicate ~~July~~by ~~24,~~check ~~2026,~~mark ~~HCA~~whether ~~Healthcare, Inc. (~~the ~~“Company”)~~registrant ~~issued~~is aan ~~press~~emerging ~~release~~growth ~~announcing,~~company ~~among~~as ~~other~~defined ~~matters,~~in ~~its~~Rule ~~results~~405 of ~~operations~~the ~~for~~Securities ~~the~~Act ~~second~~of ~~quarter~~1933 ~~ended~~(17 ~~June~~CFR ~~30,~~§230.405) ~~2026,~~or ~~the~~Rule ~~text~~12b-2 of ~~which~~the isSecurities ~~set~~Exchange ~~forth~~Act asof ~~Exhibit~~1934 99(17 CFR §240.112b-2).

~~Item~~Emerging ~~7.01.~~growth ~~Regulation FD Disclosure.~~company ☐

OnIf ~~July~~an 24emerging ~~2026~~growth company, ~~the~~indicate ~~Company~~by ~~issued~~check amark ~~press~~if ~~release~~the ~~announcing,~~registrant ~~among~~has ~~other~~elected ~~matters,~~not ~~its~~to ~~results~~use ofthe ~~operations~~extended transition period for ~~the~~complying ~~second~~with ~~quarter~~any ~~ended~~new ~~June~~or ~~30,~~revised ~~2026,~~financial ~~the~~accounting ~~text~~standards ofprovided ~~which~~pursuant isto ~~set~~Section 13(a) ~~forth~~of asthe ~~Exhibit~~Exchange 99Act.1. ☐

Item 82.0103. ~~Other~~Creation ~~Events~~of a Direct Financial Obligation or an Obligation or an Off-Balance Sheet Arrangement of a Registrant.

OnThe ~~July~~information ~~24,~~set ~~2026,~~forth ~~the~~under ~~Company~~Item ~~announced~~8.01 ~~that~~below ~~its~~is ~~Board~~incorporated ofby ~~Directors~~reference ~~had~~into ~~declared~~this aItem ~~quarterly cash dividend of $0~~2.~~78 per share of the Company’s common stock~~03. ~~The dividend will be paid on September 30, 2026 to stockholders of record at the close of business on September 16, 2026.~~

Item 98.01. ~~Financial~~Other ~~Statements and Exhibits.~~Events

On July 29, 2026, HCA Inc. (dthe “Issuer”), ~~Exhibits:~~a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), increased the size of its commercial paper program under which the Issuer may issue unsecured commercial paper notes (the “Notes”) from time to time from a maximum aggregate face or principal amount of $4.0 billion outstanding at any time to a maximum aggregate face or principal amount of $8.0 billion outstanding at any time. The Notes are unconditionally guaranteed by the Parent Guarantor. The other terms and conditions of the commercial paper program remain as previously described in the Parent Guarantor’s Current Report on Form 8-K filed with the Securities and Exchange Commission on June 10, 2025.

Exhibit 99.1		Press Release, dated July 24, 2026
Exhibit 104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

The Notes (and the related guarantee by the Parent Guarantor) have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or state securities laws and have not been and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. The information contained in this Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any Notes.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			HCA HEALTHCARE, INC.
Date:	July 24, 2026	By:	/s/ Michael A. Marks
			Michael A. MarksExecutive Vice President and Chief Financial Officer


HCA HEALTHCARE, INC.

By:		/s/ John M. Franck II
		John M. Franck II
		Vice President - Legal and Corporate Secretary

Date: July 29, 2026

Filing Compare · HCA Healthcare, Inc.